Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from TELA Bio ( (TELA) ) is now available.
On March 17, 2026, TELA Bio disclosed that it had received a Nasdaq deficiency notice after its shares closed below the $1.00 minimum bid price for 30 consecutive business days, jeopardizing its compliance with Nasdaq Global Market listing rules. The notice does not immediately affect trading, and the company has until September 14, 2026, with a potential additional 180-day period and possible transfer to the Nasdaq Capital Market, to restore its share price or otherwise face potential delisting and a possible appeal process.
TELA Bio plans to closely monitor its stock price and evaluate options to regain compliance, but it cautioned that there is no certainty it can meet the minimum bid threshold or secure further extensions if needed. The situation introduces added regulatory and listing risk for shareholders, underscoring the company’s current market valuation pressures and the possibility of an eventual move to a lower-tier market or delisting if remediation efforts fail.
The most recent analyst rating on (TELA) stock is a Hold with a $0.84 price target. To see the full list of analyst forecasts on TELA Bio stock, see the TELA Stock Forecast page.
Spark’s Take on TELA Stock
According to Spark, TipRanks’ AI Analyst, TELA is a Neutral.
TELA Bio’s overall stock score is primarily impacted by its weak financial performance, characterized by high leverage and ongoing losses. Technical analysis and valuation further weigh down the score due to bearish trends and a negative P/E ratio. Despite these challenges, the company is taking strategic steps to improve its financial position and operational efficiency, as highlighted in the earnings call and recent corporate events.
To see Spark’s full report on TELA stock, click here.
More about TELA Bio
TELA Bio, Inc. is a medical technology company whose common stock trades on the Nasdaq Global Market under the symbol TELA. The company operates in the healthcare sector and is subject to Nasdaq’s continued listing standards, including minimum bid price requirements for its publicly traded common shares.
Average Trading Volume: 160,883
Technical Sentiment Signal: Sell
Current Market Cap: $33.4M
Find detailed analytics on TELA stock on TipRanks’ Stock Analysis page.